Fig. 6From: Multi-algorithms analysis for pre-treatment prediction of response to transarterial chemoembolization in hepatocellular carcinoma on multiphase MRIDecision curve analysis (DCA) was used to evaluate the clinical value of the trained models for TACE response. The y-axis measures the net benefit and the x-axis represents the threshold probability. CD model provided the highest net benefit compared with rival models. CL model, Clinical & Lasso merged model; CD model, Clinical & DNN merged model; All, All interventions strategy; None, No intervention at all strategyBack to article page